Internal Medicine, Hematology & Oncology · Chesapeake, VA
NPI
1588191662
Since 2017
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
110 Wimbledon Sq Ste E
Chesapeake, VA, 23320
Phone (757) 436-2995
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
2,082 services
Medicare patients, 2024
386
Average age 76
Drug cost, 2024
$2.8M
983 prescriptions
Company payments, 2025
$606
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michail Alevizakos was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 865 times for 308 patients. In total Michail Alevizakos billed 2,082 services in 27 codes, and Medicare paid $110K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 865 | 308 | $12.22 | $11K |
| 99214 Office E&M - Established | Office | 599 | 279 | $67.72 | $41K |
| 99215 Office E&M - Established | Office | 363 | 95 | $107.41 | $39K |
| 99233 Hospital E&M - Subsequent | Facility | 61 | 35 | $90.34 | $5,511 |
| 99232 Hospital E&M - Subsequent | Facility | 49 | 28 | $53.86 | $2,639 |
| 99205 Office E&M - New | Office | 37 | 37 | $124.92 | $4,622 |
| 99223 Hospital E&M - Initial | Facility | 21 | 18 | $131.88 | $2,769 |
| 99204 Office E&M - New | Office | 18 | 18 | $84.69 | $1,524 |
| 99213 Office E&M - Established | Office | 17 | 17 | $49.69 | $845 |
By year: 2023 $14K for 183 services; 2024 $110K for 2,082 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michail Alevizakos prescribed most often to Medicare patients was Hydroxyurea, with 67 prescriptions and refills. In total Michail Alevizakos wrote 983 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 67 | 121 | 15 | $1,225 |
| Eliquis Apixaban | 64 | 75 | 15 | $43K |
| Xarelto Rivaroxaban | 63 | 107 | 13 | $57K |
| Imbruvica Ibrutinib | 56 | 56 | Under 11 | $579K |
| Acyclovir Generic | 48 | 78 | 13 | $783 |
| Dexamethasone Generic | 43 | 57 | 17 | $1,219 |
| Morphine Sulfate Er Morphine Sulfate | 38 | 38 | Under 11 | $1,990 |
| Jakafi Ruxolitinib Phosphate | 35 | 35 | Under 11 | $577K |
| Revlimid Lenalidomide | 34 | 34 | 13 | $600K |
| Ondansetron Hcl Generic | 31 | 31 | 20 | $559 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 30 | 47 | Under 11 | $109 |
| Calquence Acalabrutinib Maleate | 30 | 30 | Under 11 | $361K |
| Hydromorphone Hcl Generic | 30 | 30 | Under 11 | $1,339 |
| Prochlorperazine Maleate Generic | 28 | 28 | 18 | $945 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 23 | 23 | 16 | $321 |
Brand drugs: - claims; generic drugs: 620 claims; opioid claims: 117.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michail Alevizakos $606 ($606 in general payments such as food, travel and fees) from 13 companies. The largest payer was Geron Corporation with $137.
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation GERN | 1 | $137 |
| PharmaEssentia USA Corporation 6446.TW | 3 | $81.08 |
| Abbvie Inc. ABBV | 3 | $69.48 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $62.73 |
| Janssen Biotech, Inc. JNJ | 2 | $59.28 |
| GlaxoSmithKline, LLC. GSK | 2 | $38.64 |
| Taiho Oncology, Inc. 4578.T | 1 | $30.39 |
| Pfizer Inc. PFE | 1 | $24.72 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $23.39 |
| Merck Sharp & Dohme LLC MRK | 1 | $21.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.